Decay acceleration of the complement alternative pathway C3 convertase

Immunopharmacology

Volumn 42, Issue 1-3, 1999, Pages 167-173

  Hourcade, Dennis E ^a   Mitchell, Lynne M ^a   Medof, M Edward ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complement; Convertase; DAF; Decay accelerating factor; Decay acceleration; Factor B; Factor H

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT FACTOR H; DECAY ACCELERATING FACTOR; MEMBRANE PROTEIN; REGULATOR PROTEIN;

COMPLEMENT ALTERNATIVE PATHWAY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0032997017     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00005-3     Document Type: Conference Paper

References (28)

1. Brodbeck W.G., Liu D., Sperry J., Mold C., Medof M.E. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. J. Immunol. 156:1996;2528-2533.
2. Caras I.W., Davitz M.A., Rhee L., Weddell G., Martin D.W. Jr., Nussenzweig V. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature. 325:1987;545-549.
3. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:1998;545-568.
4. Davis, A.E., III, 1998. C1 inhibitor gene and hereditary angioedema. In: Volanakis, J.E., Frank, M.M. (Eds.), The Human Complement System in Health and Disease. Marcel Dekker, New York, pp. 455-480.
5. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-54.
6. Fehlhammer H., Bode W., Huber R. Crystal structure of bovine trypsinogen at 1-8 A resolution: II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J. Mol. Biol. 111:1977;415-438.
7. Fishelson Z., Müller-Eberhard H.J. C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium. J. Immunol. 129:1982;2603-2607.
8. Freer S.T., Kraut J., Robertus J.D., Wright H.T., Xuong N.H. Chymotrypsinogen: 2.5-A crystal structure, comparison with a-chymotrypsin, and implications for zynogen activation. Biochemistry. 9:1970;1997-2009.
9. Horiuchi T., Macon K.J., Engler J.A., Volanakis J.E. Site-directed mutagenesis of the region around cys-241 of complement component C2. J. Immunol. 147:1991;584-589.
10. Hourcade D., Holers V.M., Atkinson J.P. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45:1989;381-416.
11. Hourcade D.E., Wagner L.M., Oglesby T.J. Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis. J. Biol. Chem. 270:1995;19716-19722.
12. Hourcade D.E., Mitchell L.M., Oglesby T.J. A conserved element in the serine protease domain of complement factor B. J. Biol. Chem. 273:1998;25996-26000.
13. Kristensen T., D'Eustachio P., Ogata R.T., Chung L.P., Reid K.B.M., Tack B.F. The superfamily of C3b/C4b-binding proteins. Federation Proceedings. 46:1991;2463-2469.
14. Kuhn S., Zipfel P.F. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur. J. Immunol. 26:1996;2383-2387.
15. Kuttner-Kondo L., Medof M.E., Brodbeck W., Shoham M. Molecular modeling and mechanism of action of human decay-accelerating factor. Protein Eng. 9:1996;1143-1149.
16. Lambris J.D., Müller-Eberhard H.J. Isolation and characterization of a 33,000-Dalton fragment of complement factor B with catalytic and C3b binding activity. J. Biol. Chem. 259:1984;12685-12690.
17. Liszewski, M.K., Atkinson, J.P., 1998. Regulatory proteins of complement. In: Volanakis, J.E., Frank, M.M. (Eds.), The Human Complement System in Health Disease. Marcel Dekker, New York, pp. 149-165.
18. Medof M.E., Walter E.I., Roberts W.L., Haas R., Rosenberry T.L. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry. 25:1986;6740-6747.
19. Medof M.E., Lublin D.M., Holers V.M., Ayers D.J., Getty R.R., Leykam J.F., Atkinson J.P., Tykocinski M.L. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. U.S.A. 84:1987;2007-2011.
20. Müller-Eberhard, H.J., 1992. Inflammation: Basic Principles and Clinical Correlates. In: Gallin, J., Goldstein, I., Snyderman, R. (Eds.), Complement: Chemistry and Pathways. Raven Press, New York, pp. 33-62.
21. Polley M.J., Müller-Eberhard H.J. Enhancement of the hemolytic activity of the second component of human complement by oxidation. J. Exp. Med. 126:1967;1013-1025.
22. Pryzdial E.L.G., Isenman D.E. Alternative complement pathway activation fragment Ba binds to C3b. J. Biol. Chem. 262:1987;1519-1525.
23. Smith C.A., Vogel C.W., Müller-Eberhard H.J. MHC class III products: an electron microscope study of the C3 convertase of human complement. J. Exp. Med. 159:1984;324-329.
24. Tuckwell D.S., Xu Y., Newham P., Humphries M.J., Volanakis J.E. Surface loops adjacent to the cation-binding site of the complement factor B von Willebrand factor type A module determine C3b binding specificity. Biochemistry. 36:1997;6605-6613.
25. Ueda A., Kearney J.F., Roux K.H., Volanakis J.E. Probing functional sites on complement protein B with monoclonal antibodies. J. Immunol. 138:1987;1143-1149.
26. Vogel C.W., Müller-Eberhard H.J. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J. Biol. Chem. 257:1982;8292-8299.
27. Volanakis, J.E., 1998. Overview of the complement system. In: Volanakis, J.E., Frank, M.M. (Eds.), The Human Complement System in Health and Disease. Marcel Dekker, New York, pp. 9-32.
28. Volanakis, J.E., Arlaud, G.J., 1998. Complement enzymes. In: Volanakis, J.E., Frank, M.M. (Eds.), The Human Complement System in Health and Disease. Marcel Dekker, New York, pp. 49-81.